What’s in the Ozempic Shot? Ingredients and Science Explained

Last reviewed: June 17, 2026

Last updated: June 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections contain a synthetic version of GLP-1, a hormone your gut naturally produces when you eat. This medication activates receptors in your brain that regulate hunger signals, slow stomach emptying, and improve how your body uses insulin. Understanding the science behind semaglutide can help you make informed decisions about whether this therapy fits your weight loss goals.

What Is the Active Ingredient in Semaglutide Injections?

The active ingredient in semaglutide is a 31-amino-acid peptide molecule engineered to bind tightly to GLP-1 receptors in your brain and pancreas. Unlike the natural GLP-1 hormone your body produces, semaglutide has been chemically modified to resist breakdown in your bloodstream, extending its effect to about one week per injection. This structural difference allows a single weekly dose to maintain therapeutic levels throughout the week, making it more convenient than daily medications.

Semaglutide was first developed for type 2 diabetes management, where clinical trials showed it improved blood sugar control in patients who also experienced significant weight loss. The weight loss effect became so pronounced that physicians began prescribing it off-label for weight management in people without diabetes, leading to the development of higher-dose formulations specifically for obesity treatment. PlexusDx sources compounded semaglutide from licensed 503A pharmacies, ensuring the same active pharmaceutical ingredient under stricter quality oversight than many other suppliers.

How Semaglutide Works in Your Body to Reduce Appetite

When you inject semaglutide, it travels through your bloodstream and crosses into your brain, where it attaches to GLP-1 receptors located in the hypothalamus—the region responsible for hunger regulation. Activation of these receptors sends a signal to reduce your appetite and increase feelings of fullness, even when you consume fewer calories than usual. This mechanism differs fundamentally from older appetite suppressants because it works on your body's own regulatory systems rather than stimulating your nervous system.

Beyond appetite suppression, semaglutide slows the rate at which food moves from your stomach into your small intestine, a process called gastric emptying. This slower digestion prolongs feelings of satiety and helps prevent blood sugar spikes after meals. Additionally, semaglutide enhances insulin secretion when blood glucose rises, supporting better metabolic control. These combined effects—reduced hunger, slower digestion, and improved insulin response—create a powerful environment for sustained weight loss without requiring extreme caloric restriction.

Complete Formulation: Active and Inactive Components in Each Injection

Beyond semaglutide itself, each injection contains several inactive ingredients that ensure stability, sterility, and proper delivery. These include sodium phosphate dibasic dihydrate, sodium phosphate monobasic dihydrate, and sodium chloride, which together maintain the pH and osmolality necessary for safe injection into muscle or subcutaneous tissue. Water for injection serves as the vehicle, and the solution is filtered and tested for bacterial and pyrogenic contamination before dispensing.

Compounded semaglutide from PlexusDx providers follows the same pharmaceutical standards as brand-name products, with each batch tested for potency and purity. The 503A compounding pharmacy model allows for custom dosing strengths while maintaining strict quality controls established by the United States Pharmacopeia. Patients receive detailed ingredient lists with each shipment, ensuring transparency about exactly what they are injecting.

Genetic Factors That Influence How Your Body Responds to Semaglutide

Your response to semaglutide therapy depends partly on genetic variations in the GLP1R gene, which codes for the receptor semaglutide binds to in your brain and pancreas. The rs6923761 variant is one key genetic marker that influences how effectively your cells respond to semaglutide activation. Some individuals carry genetic variants that reduce GLP-1 receptor sensitivity, potentially requiring higher doses or different therapeutic approaches for optimal results.

PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 peptide-regulating pathways and examines variants like GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 to predict your individual medication response. This test, available as a $99 add-on after your first month of treatment, maps 150+ genetic insights across 49 peptides, allowing your provider to tailor your therapy based on your unique biology. Understanding your genetic predispositions can help optimize dosing strategy and potentially identify whether semaglutide, tirzepatide, or combination therapy will deliver the best results for your body.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide the same as brand-name Ozempic or Wegovy?

Compounded semaglutide contains the identical active ingredient as brand-name products and is manufactured in licensed 503A compounding pharmacies under the same regulatory standards. The main difference is cost—PlexusDx compounded semaglutide starts at $149 per month compared to significantly higher prices for brand-name versions. Both deliver the same pharmacological effect, though your provider may recommend brand-name products if you have specific preferences.

What happens if my body doesn't respond well to semaglutide's active ingredient?

If semaglutide doesn't produce adequate weight loss after 3-4 months at therapeutic dose, your PlexusDx provider may recommend switching to tirzepatide, which activates both GLP-1 and GIP receptors for a broader metabolic effect. The Precision Peptide Genetic Test can help identify if a genetic variant affecting GLP1R sensitivity explains poor response, potentially pointing toward tirzepatide or dual-compound therapy like GLP-Squared as better alternatives.

Can I afford semaglutide injections without insurance through PlexusDx?

Yes. PlexusDx compounded semaglutide injections start at $149 per month with no insurance required and no membership fees. The medication is HSA and FSA eligible, making it accessible for most patients. Your dose may need to increase over time for continued weight loss, but your price remains flat—PlexusDx does not charge more as your dose increases.

What side effects should I expect from the ingredients in semaglutide injections?

The most common side effects—nausea, vomiting, constipation, and diarrhea—stem from semaglutide's effect on stomach emptying and appetite regulation, not from inactive ingredients. These symptoms typically diminish after 2-4 weeks as your body adjusts. Serious side effects are rare but can include pancreatitis or allergic reactions; inform your provider immediately if you experience severe abdominal pain or difficulty breathing.

How does the PlexusDx Precision Peptide Genetic Test help predict my semaglutide response?

The test examines your GLP1R rs6923761 variant and 49 other peptide-pathway genes to estimate how strongly your body's receptors will respond to semaglutide. If you carry variants associated with lower receptor sensitivity, your provider may recommend starting with tirzepatide or a dual-compound approach instead. This personalized insight, available for $99 after your first treatment month, helps optimize your therapy from the start and reduces trial-and-error dosing.

Related Reading

• Ozempic Shot
• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.